AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at the Leerink Partners 2026 Global Healthcare Conference on March 11, 2026 at 9:20 a.m. ET.

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the Leerink Partners 2026 Global Healthcare Conference on March 11, 2026 at 9:20 a.m. ET. Peter Griffith, CFO, and Jasper van Grunsven, SVP of Rare Disease, will take part in a fireside chat. The event will be webcast live and archived for at least 90 days.

The webcast will be available to media, investors, and the public via Amgen's Investor Relations Events Calendar and archived on Amgen's website for replay.

Argus Mar 6 session

+0.53% close to close 0.9x rel. volume Open Argus

Details

News Market Reaction – AMGN

On Mar 6, the first trading day after this news, AMGN closed 0.53% above the previous close.

Data tracked by StockTitan Argus for the Mar 6 session.

Key Figures

Conference time: 9:20 a.m. ET Conference date: March 11, 2026 Webcast archive period: 90 days

Conference time

9:20 a.m. ET

Leerink Partners 2026 Global Healthcare Conference presentation time

Conference date

March 11, 2026

Scheduled date of Amgen’s conference appearance

Webcast archive period

90 days

Minimum replay availability for the conference webcast

Historical Context

5 past events · Latest: Feb 24

5 events

1. Feb 24

   Investor conference

   24h Move

   +0.4%

   TD Cowen health care conference webcast and management presentation details.

2. Feb 13

   Investor conference

   24h Move

   +1.1%

   Citi virtual oncology leadership summit appearance and webcast access.

3. Feb 03

   Earnings results

   24h Move

   +8.2%

   Q4 and 2025 results with revenue, product sales and GAAP EPS growth.

4. Jan 28

   Earnings webcast

   24h Move

   +0.2%

   Scheduling and webcast details for Q4 and full-year 2025 results call.

5. Jan 20

   Legal action

   24h Move

   +0.2%

   Lawsuit over prescription drug access involving a large pharmaceutical company.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., March 5, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Leerink Partners 2026 Global Healthcare Conference at 9:20 a.m. ET on Wednesday, March 11, 2026. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jasper van Grunsven, senior vice president of rare disease at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. 

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. 

About Amgen  
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. 

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.  

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.  

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads. 

CONTACT: Amgen, Thousand Oaks 
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-leerink-partners-2026-global-healthcare-conference-302705704.html

SOURCE Amgen

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Amgen (AMGN) present at the Leerink Partners 2026 Global Healthcare Conference?

Amgen will present on March 11, 2026 at 9:20 a.m. ET. According to Amgen, the presentation is scheduled as a fireside chat featuring senior executives and will be webcast live for public viewing and archived for replay.

Who will represent Amgen (AMGN) in the fireside chat on March 11, 2026?

Peter Griffith (CFO) and Jasper van Grunsven (SVP, Rare Disease) will participate in the fireside chat. According to Amgen, both executives will discuss company developments during the session and answer investor-focused questions.

How can investors watch Amgen's (AMGN) Leerink 2026 presentation live or on replay?

The presentation will be webcast live and archived for replay for at least 90 days. According to Amgen, viewers can access the live webcast and archived replay via the Investor Relations Events Calendar on Amgen's website.

Will Amgen's (AMGN) Leerink 2026 webcast be available to the general public and media?

Yes, the webcast is open to media, investors, and the general public. According to Amgen, the simultaneous internet broadcast ensures public access and the archived replay will remain available for at least 90 days post-event.

Where is the archived replay of Amgen's (AMGN) March 11, 2026 presentation hosted and for how long?

The archived replay will be hosted on Amgen's website under Investors and archived for at least 90 days. According to Amgen, the replay link and event timing are listed on the Investor Relations Events Calendar.

Will Amgen (AMGN) discuss rare disease programs during the Leerink Partners 2026 fireside chat?

Yes, rare disease topics are expected given a participant's role as SVP of Rare Disease. According to Amgen, Jasper van Grunsven will participate in the fireside chat and may address developments in the rare disease portfolio.